Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: June 28, 2022

Drug Price Trends for LEFLUNOMIDE

✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for LEFLUNOMIDE

Average Pharmacy Cost for LEFLUNOMIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEFLUNOMIDE 10 MG TABLET 10702-0277-03 0.99862 EACH 2021-06-23
LEFLUNOMIDE 10 MG TABLET 50268-0477-11 0.99862 EACH 2021-06-23
LEFLUNOMIDE 10 MG TABLET 50268-0477-15 0.99862 EACH 2021-06-23
LEFLUNOMIDE 10 MG TABLET 23155-0043-03 0.99862 EACH 2021-06-23
LEFLUNOMIDE 20 MG TABLET 70748-0130-06 0.92470 EACH 2021-06-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LEFLUNOMIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEFLUNOMIDE 10MG TAB AvKare, Inc. 42291-0420-30 30 18.82 0.62733 EACH 2020-02-22 - 2022-12-31 FSS
LEFLUNOMIDE 20MG TAB AvKare, Inc. 42291-0421-30 30 19.92 0.66400 EACH 2020-02-22 - 2022-12-31 FSS
ARAVA TABLETS 20MG Sanofi Aventis U.S. LLC 00088-2161-30 30 1155.42 38.51400 EACH 2021-01-01 - 2022-09-14 FSS
LEFLUNOMIDE 10MG TAB Sanofi Aventis U.S. LLC 00955-1735-30 30 4.14 0.13800 EACH 2022-01-01 - 2022-09-14 Big4
ARAVA TABLETS 10MG Sanofi Aventis U.S. LLC 00088-2160-30 30 993.75 33.12500 EACH 2022-01-01 - 2022-09-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.